Tech company Vehicle Management Systems has come up short in its third attempt to block competitor SARB Management Group’s patent application for a magnetic parking overstay detector, with the Full Court rejecting claims that VMS’ managing director should have been listed as the device’s inventor.
Union members who allegedly urged former Qantas workers to give misleading information to the Federal Court via a survey in a lawsuit brought on behalf of 2,000 stood-down ground staff may be called to explain themselves after a judge expressed concern over their conduct.
Liberty Mutual Insurance does not have to indemnify dam operator Sunwater for its share of a $440 million settlement of the Queensland floods class action, the NSW Supreme Court has found.
The Port of Newcastle has largely won its High Court fight with mining giant Glencore over access fees and will now be able to set a higher price for use of the port’s facilities.
The High Court has granted the ATOâs bid to impose a worldwide freezing order against Chinese property developer Changran Huang, saying the courtâs power to freeze assets did not depend on whether there was a realistic possibility of enforcing a judgment in a foreign jurisdiction.
An appeals court has found it âinconceivableâ that legislation aimed at protecting public health would not have afforded the New South Wales health minister the power to mandate COVID-19 vaccinations for certain workers, given the outbreak of the Delta strain of the coronavirus.
Group members in a class action over Bayer’s Essure contraceptives had âa ticking time bombâ in their bodies after being implanted with the devices, and all were at risk of developing injuries, a court has heard.
Coffee giant Vittoria has lost its bid to register the trade mark âVictoria Coffee”, with IP Australia finding the mark could prevent other businesses from honestly describing coffee products by referring to the state of Victoria.
A judge was “mistaken” to find that AFT Pharmaceuticals’ ads for its painkiller Maxigesic were misleading, with the Full Federal Court ruling there was an adequate scientific foundation for the ads’ claims that the drug provided faster, better pain relief than paracetamol and ibuprofen alone.
Mercedes-Benz has responded to a $650 million lawsuit by Australian dealers over its decision to move to a fixed-price agency model, saying it had a “legitimate commercial interest” in making the change and denying that dealer agreements were “perpetual” in their terms.